Steroid-responsive Nivolumab-induced Involuntary Movement with Anti-thyroid Antibodies-Reference-Cited by-同舟云学术

Steroid-responsive Nivolumab-induced Involuntary Movement with Anti-thyroid Antibodies

Published:2019-12-15 Issue:24 Volume:58 Page:3577-3581
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Maetani Yuta¹,Nezu Tomohisa¹,Ueno Hiroki¹,Aoki Shiro¹,Hosomi Naohisa¹,Maruyama Hirofumi¹

Affiliation:

1. Department of Clinical Neuroscience and Therapeutics, Hiroshima University Faculty of Medicine Graduate School of Biomedical and Health Sciences, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/58/24/58_3200-19/_pdf

Reference10 articles.

1. 1. Larkin J, Chmielowski B, Lao CD, et al. Neurologic serious adverse events associated with nivolumab plus ipilimumab or nivolumab alone in advanced melanoma, including a case series of encephalitis. Oncologist 22: 709-718, 2017.

2. 2. Suzuki S, Ishikawa N, Konoeda F, et al. Nivolumab-related myasthenia gravis with myositis and myocarditis in Japan. Neurology 89: 1127-1134, 2017.

3. 3. Sharma P, Allison JP. The future of immune checkpoint therapy. Science 348: 56-61, 2015.

4. 4. Suzuki S, Tanaka K, Yasuoka H, Fukuuchi Y, Kawakami Y, Kuwana M. Autoreactive T cells to the P3A+ isoform of AChR alpha subunit in myasthenia gravis. J Neuroimmunol 137: 177-186, 2003.

5. 5. Yoneda M, Fujii A, Ito A, Yokoyama H, Nakagawa H, Kuriyama M. High prevalence of serum autoantibodies against the amino terminal of alpha-enolase in Hashimoto's encephalopathy. J Neuroimmunol 185: 195-200, 2007.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autoimmune Movement Disorders Complicating Treatment with Immune Checkpoint Inhibitors;Movement Disorders Clinical Practice;2024-02-23

3. Drug-Induced Tremors;Contemporary Clinical Neuroscience;2023

4. Risk Factors for Thyroid Dysfunction in Patients with Advanced Non-Small-Cell Lung Cancer Treated with PD-1 Antibody;Evidence-Based Complementary and Alternative Medicine;2022-08-12

5. Drug-induced tremor, clinical features, diagnostic approach and management;Journal of the Neurological Sciences;2022-04